IRIS
PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.443
EU - Europa 664
AS - Asia 536
AF - Africa 113
SA - Sud America 76
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.835
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.417
SG - Singapore 361
IT - Italia 254
IE - Irlanda 190
CN - Cina 135
CI - Costa d'Avorio 72
DE - Germania 66
BR - Brasile 62
UA - Ucraina 48
RU - Federazione Russa 43
SN - Senegal 25
CA - Canada 22
NG - Nigeria 14
CZ - Repubblica Ceca 13
NL - Olanda 12
GB - Regno Unito 11
FR - Francia 8
IN - India 8
CH - Svizzera 7
HK - Hong Kong 7
VN - Vietnam 6
IQ - Iraq 5
PE - Perù 5
FI - Finlandia 3
GR - Grecia 3
JP - Giappone 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
AT - Austria 2
AU - Australia 2
CL - Cile 2
CO - Colombia 2
EC - Ecuador 2
MX - Messico 2
SE - Svezia 2
TH - Thailandia 2
AZ - Azerbaigian 1
DO - Repubblica Dominicana 1
ES - Italia 1
EU - Europa 1
HN - Honduras 1
KG - Kirghizistan 1
KR - Corea 1
LB - Libano 1
PL - Polonia 1
PY - Paraguay 1
TG - Togo 1
ZA - Sudafrica 1
Totale 2.835
Salva come PNG Salva come JPEG
Città #
Santa Clara 455
Singapore 250
Dublin 190
Chandler 179
Chicago 102
Abidjan 72
Ashburn 72
Boardman 68
Civitanova Marche 65
Cambridge 50
Jacksonville 50
Lawrence 50
Andover 38
Catania 30
Nanjing 28
Bremen 26
Dakar 25
Des Moines 24
Saint Petersburg 17
Toronto 17
Milan 15
Abuja 14
Wilmington 14
Brno 13
Los Angeles 12
Washington 11
Council Bluffs 9
Nanchang 9
Rome 9
Beijing 6
Frankfurt am Main 6
Hong Kong 6
Redwood City 6
Shenyang 6
Amsterdam 5
Arequipa 5
Genoa 5
Hebei 5
San Francisco 5
San Mateo 5
Tianjin 5
Bernareggio 4
Changsha 4
Dong Ket 4
Pune 4
Turin 4
Baghdad 3
Bari 3
Falls Church 3
Favara 3
Guangzhou 3
Jiaxing 3
Lappeenranta 3
Messina 3
Misterbianco 3
Naples 3
Ottawa 3
Reggio Emilia 3
Seattle 3
São Paulo 3
Tokyo 3
Altamura 2
Ansbach 2
Bangkok 2
Basel 2
Birmingham 2
Brescia 2
Cagliari 2
Costa di Rovigo 2
Enna 2
Esslingen am Neckar 2
Gravina di Catania 2
Hanoi 2
Moscow 2
Nardò 2
Ningbo 2
Nuremberg 2
Paris 2
Prineville 2
Quirinópolis 2
Redmond 2
Shanghai 2
Sorbo San Basile 2
São Carlos 2
Tortona 2
Angatuba 1
Araçuaí 1
Areado 1
Asunción 1
Baku 1
Balneário Piçarras 1
Barueri 1
Bela Vista 1
Belo Horizonte 1
Bergamo 1
Bishkek 1
Brasília 1
Brooklyn 1
Busan 1
Campina Grande 1
Totale 2.107
Salva come PNG Salva come JPEG
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 79
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 71
Serum YKL-40 in children with asthma 66
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 63
Minor pulmonary malformations in a child 60
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 60
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 60
Lactoferrin: Cytokine modulation and application in clinical practice 60
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 59
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 59
Exhaled breath temperature in astmatic children 58
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 58
HMGB1 values and response to HBV vaccine in children with celiac disease 58
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 58
Lung clearance index: A new measure of late lung complications of cancer therapy in children 58
Severe Kawasaki disease in a 3-month-old patient: a case report. 55
Liver disease in Cystic Fibrosis: an update 54
Cetirizine use in childhood: An update of a friendly 30-year drug 54
Hypertransaminasemia in children is not always as simple as it seems 54
Novel therapeutic targets for allergic airway disease in children 52
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 51
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 50
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 50
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 49
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 49
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 49
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 48
Biomarkers in pediatric lung diseases including cystic fibrosis 48
Genetic disorders of surfactant deficiency and neonatal lung disease 48
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 48
Severe disease in Cystic Fibrosis and fecal calprotectin levels 47
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 47
Antihistamines in children and adolescents: A practical update 47
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 47
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 46
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 46
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 45
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 45
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 44
Lung clearance index for evaluation of late complications of cancer therapy in children 44
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 44
Antihistamines: ABC for the pediatricians 44
The immunomodulatory role of vitamin D in respiratory diseases 43
Lower airway microbiota 42
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 41
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 41
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 40
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 39
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 38
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 38
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 37
Type 2 inflammation in cystic fibrosis: New insights 37
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 36
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 33
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 31
Upper and lower airways diseases in childhood 29
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 20
Pidotimod in allergic diseases 16
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 14
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 13
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 11
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 11
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 11
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 10
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 10
Protracted bacterial bronchitis: more to know 10
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 8
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 8
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 8
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 8
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 8
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 8
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 8
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 8
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 6
Nasal microbiome in chronic rhinosinusitis 5
Totale 2.958
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.009
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.009
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 0 0 0 0 0 0 0 0 0 0 12 5
2020/2021154 0 5 20 12 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.297 47 188 68 112 292 296 45 27 73 145 4 0
Totale 2.958